应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ILMN Illumina
盘后交易 04-02 18:02:56 EDT
81.88
+3.49
+4.45%
盘后
80.48
-1.40
-1.71%
17:51 EDT
最高
82.76
最低
77.99
成交量
190.57万
今开
78.27
昨收
78.39
日振幅
6.09%
总市值
129.70亿
流通市值
129.28亿
总股本
1.58亿
成交额
1.56亿
换手率
1.21%
流通股本
1.58亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
因美纳4月1日成交额为1.47亿美元
市场透视 · 04-02 09:40
因美纳4月1日成交额为1.47亿美元
因美纳3月27日成交额为1.49亿美元
市场透视 · 03-28
因美纳3月27日成交额为1.49亿美元
因美纳,换董事长了,曾任FDA局长!
IVD资讯 · 03-26
因美纳,换董事长了,曾任FDA局长!
因美纳与NashBio完成25万全基因组测序 推动药物研发新阶段
DoNews · 03-24
因美纳与NashBio完成25万全基因组测序 推动药物研发新阶段
基因组发现联盟完成25万个全基因组测序,将推动药物研发提速
美通社 · 03-21
基因组发现联盟完成25万个全基因组测序,将推动药物研发提速
【RBC Capital下调Illumina目标价至128美元】RBC Capital:将Illumina的目标价从247美元下调至128美元,维持“跑赢大盘”评级。(格隆汇)
金融界 · 03-13
【RBC Capital下调Illumina目标价至128美元】RBC Capital:将Illumina的目标价从247美元下调至128美元,维持“跑赢大盘”评级。(格隆汇)
Stephens & Co.:重申Illumina(ILMN.US)评级,由增持调整至增持评级, 目标价由156.00美元调整至156.00美元。
金融界 · 03-11
Stephens & Co.:重申Illumina(ILMN.US)评级,由增持调整至增持评级, 目标价由156.00美元调整至156.00美元。
因美纳盘中异动 大幅上涨5.04%
市场透视 · 03-11
因美纳盘中异动 大幅上涨5.04%
被禁止向中国出口基因测序仪的因美纳,正在制定成本削减计划
第一财经 · 03-11
被禁止向中国出口基因测序仪的因美纳,正在制定成本削减计划
进口禁令之下,因美纳有门路绕开处罚?
健识局 · 03-07
进口禁令之下,因美纳有门路绕开处罚?
花旗:维持Illumina(ILMN.US)评级,由中性调整至中性评级, 目标价由130.00美元调整至90.00美元。
金融界 · 03-05
花旗:维持Illumina(ILMN.US)评级,由中性调整至中性评级, 目标价由130.00美元调整至90.00美元。
异动解读 | 中国政府出重手!Illumina遭列不可靠实体清单禁止出口基因测序仪,盘前股价大跌5.11%
异动解读 · 03-04
异动解读 | 中国政府出重手!Illumina遭列不可靠实体清单禁止出口基因测序仪,盘前股价大跌5.11%
商务部再度出手!禁止美国测序巨头因美纳向中国出口基因测序仪
澎湃新闻 · 03-04
商务部再度出手!禁止美国测序巨头因美纳向中国出口基因测序仪
商务部:决定将美国因美纳公司列入不可靠实体清单
老虎资讯综合 · 03-04
商务部:决定将美国因美纳公司列入不可靠实体清单
异动解读 | Illumina盘中大跌5.42%,业绩持续下滑或为主因
异动解读 · 02-28
异动解读 | Illumina盘中大跌5.42%,业绩持续下滑或为主因
因美纳盘中异动 下午盘股价大跌5.06%报89.29美元
市场透视 · 02-28
因美纳盘中异动 下午盘股价大跌5.06%报89.29美元
因美纳跌1.08% 股价跌破100美元大关
市场透视 · 02-19
因美纳跌1.08% 股价跌破100美元大关
Illumina Full Year 2024 Earnings: EPS Misses Expectations
Simply Wall St. · 02-14
Illumina Full Year 2024 Earnings: EPS Misses Expectations
华大系如何接住Illumina的泼天富贵?
医药财经 · 02-14
华大系如何接住Illumina的泼天富贵?
因美纳跌0.94% 股价跌破100美元大关
市场透视 · 02-12
因美纳跌0.94% 股价跌破100美元大关
加载更多
公司概况
公司名称:
Illumina
所属市场:
NASDAQ
上市日期:
--
主营业务:
Illumina, Inc.是一家生命科学用具以及用于分析基因变异和基因功能的整合系统的一流开发商、制造商和销售商。公司于1998年4月在加利福尼亚州组成,2000年7月在特拉华州完成重组。公司利用专利技术提供一系列的基因分析方案以及为高度相联的市场提供产品和服务,包括基因序列、基因类型、基因表达和分子诊断市场。该公司的客户包括领先的基因组研究中心、学术机构、政府管辖的实验室、临床研究组织以及制药公司、生物科技公司、农产品基因组鉴定研发公司和客户基因组鉴定公司。
发行价格:
--
{"stockData":{"symbol":"ILMN","market":"US","secType":"STK","nameCN":"Illumina","latestPrice":81.88,"timestamp":1743624000000,"preClose":78.39,"halted":0,"volume":1905714,"hourTrading":{"tag":"盘后","latestPrice":80.48,"preClose":81.88,"latestTime":"17:51 EDT","volume":47886,"amount":3918292.54098,"timestamp":1743630718889},"delay":0,"floatShares":157886308,"shares":158400000,"eps":-7.691823,"marketStatus":"盘后交易","change":3.49,"latestTime":"04-02 18:02:56 EDT","open":78.27,"high":82.76,"low":77.99,"amount":155550314.88482398,"amplitude":0.06085,"askPrice":81.49,"askSize":105,"bidPrice":80.11,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-7.691823,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1743638400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":964756800000,"exchange":"NASDAQ","adjPreClose":78.39,"preHourTrading":{"tag":"盘前","latestPrice":78.3,"preClose":78.39,"latestTime":"09:27 EDT","volume":224,"amount":17544.187584,"timestamp":1743600460057},"postHourTrading":{"tag":"盘后","latestPrice":80.48,"preClose":81.88,"latestTime":"17:51 EDT","volume":47886,"amount":3918292.54098,"timestamp":1743630718889},"volumeRatio":1.054501,"impliedVol":0.5773,"impliedVolPercentile":0.8964},"requestUrl":"/m/hq/s/ILMN","defaultTab":"news","newsList":[{"id":"2524103020","title":"因美纳4月1日成交额为1.47亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524103020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2524103020?lang=zh_cn&edition=full","pubTime":"2025-04-02 09:40","pubTimestamp":1743558057,"startTime":"0","endTime":"0","summary":"美东时间2025年4月1日,因美纳成交额为1.47亿美元,成交额较昨日增加6.52%,当日成交量为187.05万股。因美纳于2025年4月1日跌1.2%,报78.39美元,该股过去5个交易日跌10.44%,年初至今跌41.34%,过去60日跌40.13%。因美纳的高通量技术使人类和其他大型生物的全基因组测序成为可能。因美纳还销售微阵列,可实现低成本、集中的基因筛查,主要用于消费者和农业应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250402094108a44aa6af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4548","ILMN","BK4588","BK4534","BK4535","BK4121"],"gpt_icon":0},{"id":"2522654775","title":"因美纳3月27日成交额为1.49亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522654775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2522654775?lang=zh_cn&edition=full","pubTime":"2025-03-28 09:38","pubTimestamp":1743125931,"startTime":"0","endTime":"0","summary":"美东时间2025年3月27日,因美纳成交额为1.49亿美元,成交额较昨日减少15.01%,当日成交量为181.28万股。因美纳于2025年3月27日跌0.66%,报82.28美元,该股过去5个交易日跌2.96%,年初至今跌38.43%,过去60日跌39.17%。因美纳的高通量技术使人类和其他大型生物的全基因组测序成为可能。因美纳还销售微阵列,可实现低成本、集中的基因筛查,主要用于消费者和农业应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328093900a6a6c6e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4548","BK4534","BK4588","BK4535","ILMN","BK4585"],"gpt_icon":0},{"id":"2522766870","title":"因美纳,换董事长了,曾任FDA局长!","url":"https://stock-news.laohu8.com/highlight/detail?id=2522766870","media":"IVD资讯","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2522766870?lang=zh_cn&edition=full","pubTime":"2025-03-26 12:13","pubTimestamp":1742962388,"startTime":"0","endTime":"0","summary":"来源:美通社、IVD资讯2025年3月25日,Illumina宣布了其董事会的变动。医学博士 Scott Gottlieb 当选为 Illumina 董事会非执行主席。Gottlieb 博士自 2020 年以来一直在董事会任职。此外,Corvex Management 的创始人、管理合伙人兼首席投资官 Keith Meister 将于 2025 年 3 月 28 日加入董事会。Hologic 董事长、总裁兼首席执行官 Stephen MacMillan 于 2023 年 6 月加入 Illumina 董事会,他已决定从董事会退休,为公司即将召开的年度股东大会做准备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250326202457a6a4bdb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4588","BK4535","BK4585","ILMN","BK4121","BK4548"],"gpt_icon":0},{"id":"2521795335","title":"因美纳与NashBio完成25万全基因组测序 推动药物研发新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2521795335","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2521795335?lang=zh_cn&edition=full","pubTime":"2025-03-24 16:02","pubTimestamp":1742803322,"startTime":"0","endTime":"0","summary":"因美纳公司携手NashBio宣布,“基因组发现联盟(AGD)”项目已成功完成25万个全基因组的测序任务。这一数据库的研究成果正加速药物靶点的发现、治疗研究以及临床开发进程。未来,AGD将引入多组学数据层,进一步拓展数据集的广度、深度和多样性,为精准医疗和药物研发提供更强有力的支持。此举标志着基因组学在医药领域的应用迈入全新阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032416061794becf63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ILMN","BK4548","BK4534","AGD","BK4121","BK4585","BK4535","BK4588"],"gpt_icon":0},{"id":"2521742915","title":"基因组发现联盟完成25万个全基因组测序,将推动药物研发提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2521742915","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2521742915?lang=zh_cn&edition=full","pubTime":"2025-03-21 11:35","pubTimestamp":1742528100,"startTime":"0","endTime":"0","summary":"AGD数据库的研究成果正被广泛应用于加速药物靶点发现、治疗研究及临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4646670_ZH46670_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4585","BK4121","BK4535","BK4588","BK4534","ILMN","BK4548"],"gpt_icon":0},{"id":"2519009719","title":"【RBC Capital下调Illumina目标价至128美元】RBC Capital:将Illumina的目标价从247美元下调至128美元,维持“跑赢大盘”评级。(格隆汇)","url":"https://stock-news.laohu8.com/highlight/detail?id=2519009719","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2519009719?lang=zh_cn&edition=full","pubTime":"2025-03-13 15:55","pubTimestamp":1741852523,"startTime":"0","endTime":"0","summary":"RBC Capital:将Illumina的目标价从247美元下调至128美元,维持“跑赢大盘”评级。(格隆汇)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/13155548713750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ILMN","RY"],"gpt_icon":0},{"id":"2518231477","title":"Stephens & Co.:重申Illumina(ILMN.US)评级,由增持调整至增持评级, 目标价由156.00美元调整至156.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518231477","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518231477?lang=zh_cn&edition=full","pubTime":"2025-03-11 22:52","pubTimestamp":1741704753,"startTime":"0","endTime":"0","summary":"Stephens & Co.:重申Illumina(ILMN.US)评级,由增持调整至增持评级, 目标价由156.00美元调整至156.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11225248670862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ILMN"],"gpt_icon":0},{"id":"2518741228","title":"因美纳盘中异动 大幅上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518741228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518741228?lang=zh_cn&edition=full","pubTime":"2025-03-11 21:31","pubTimestamp":1741699884,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日21时31分,因美纳股票出现异动,股价快速拉升5.04%。因美纳股票所在的生命科学行业中,整体跌幅为0.04%。因美纳的高通量技术使人类和其他大型生物的全基因组测序成为可能。因美纳被禁止向中国出口基因测序仪后,中国本土基因测序仪企业市场份额是否有望继续扩大。虽然因美纳这次被禁止向中国出口基因测序仪,但其试剂耗材业务并不受影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311213125ab5de898&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4121","BK4534","ILMN","BK4535","BK4548"],"gpt_icon":0},{"id":"2518646277","title":"被禁止向中国出口基因测序仪的因美纳,正在制定成本削减计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2518646277","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518646277?lang=zh_cn&edition=full","pubTime":"2025-03-11 14:46","pubTimestamp":1741675566,"startTime":"0","endTime":"0","summary":"因对中国企业采取歧视性措施,3月4日,中国商务部宣布禁止美国生物科技公司因美纳公司向中国出口基因测序仪。自进入中国市场以来,因美纳长期服务于本地区临床与科研客户。同时,公司正在为2025财年制定一项约1亿美元的增量成本削减计划。如2022年,中国市场占有率中,华大智造首次超过因美纳。虽然因美纳这次被禁止向中国出口基因测序仪,但其试剂耗材业务并不受影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031114480798a370a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031114480798a370a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4121","BK4588","BK4548","BK4585","ILMN","BK4534"],"gpt_icon":0},{"id":"2517448211","title":"进口禁令之下,因美纳有门路绕开处罚?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517448211","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517448211?lang=zh_cn&edition=full","pubTime":"2025-03-07 10:14","pubTimestamp":1741313655,"startTime":"0","endTime":"0","summary":"图源:因美纳官网3月4日,中国商务部发布公告,对因美纳公司采取“禁止其向中国出口基因测序仪”的处理措施。一个月前,因美纳被中国商务部以“违反正常市场交易原则,损害中国企业合法权益”为由,列入不可靠实体清单。因此试剂这一块,因美纳几乎也不受禁令影响。因美纳财报也显示,2024年前三季度因美纳在华收入同比下滑25%,仅占全球总收入的7%。换句话说,即使没有此次禁令,华大智造和因美纳也迟早会有一次正面交锋。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307101719abec2e9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","ILMN","BK4548","BK4585","BK4121","BK4535","BK4588"],"gpt_icon":0},{"id":"2517660289","title":"花旗:维持Illumina(ILMN.US)评级,由中性调整至中性评级, 目标价由130.00美元调整至90.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517660289","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517660289?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:42","pubTimestamp":1741110163,"startTime":"0","endTime":"0","summary":"花旗:维持Illumina(ILMN.US)评级,由中性调整至中性评级, 目标价由130.00美元调整至90.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05014248524160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ILMN"],"gpt_icon":0},{"id":"1157255408","title":"异动解读 | 中国政府出重手!Illumina遭列不可靠实体清单禁止出口基因测序仪,盘前股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157255408","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157255408?lang=zh_cn&edition=full","pubTime":"2025-03-04 21:30","pubTimestamp":1741095032,"startTime":"0","endTime":"0","summary":"美国基因测序设备制造商Illumina(ILMN)今日盘前股价大跌5.11%,引发了市场的广泛关注。\n\n中国商务部在今日公告中称,为维护国家主权、安全和发展利益,决定将Illumina列入不可靠实体清单,禁止该公司向中国出口基因测序仪产品。\n\n据悉,中方此前认为Illumina公司违反了正常的市场交易原则,中断了与中国企业的正常合作,并采取了歧视性措施,严重损害了中国企业的合法权益。在综合考虑公司的违法情节后,中国政府依法做出了上述处理措施。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ILMN"],"gpt_icon":0},{"id":"2516480186","title":"商务部再度出手!禁止美国测序巨头因美纳向中国出口基因测序仪","url":"https://stock-news.laohu8.com/highlight/detail?id=2516480186","media":"澎湃新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516480186?lang=zh_cn&edition=full","pubTime":"2025-03-04 14:58","pubTimestamp":1741071510,"startTime":"0","endTime":"0","summary":"3月4日,中国商务部宣布,禁止美国生物科技公司因美纳公司向中国出口基因测序仪。此前的2月4日,中国商务部宣布,将因美纳列入“不可靠实体清单”。商务部网站此前在2月4日的声明中指出,包括因美纳在内的两家企业“违反正常市场交易原则,中断与中国企业的正常合作,采取歧视性措施严重损害中国企业合法权益”。华大智造主攻被称为“国之重器”的基因测序仪。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304145942abe752fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304145942abe752fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4535","BK4121","BK4588","BK4534","BK4548","ILMN"],"gpt_icon":0},{"id":"1179393516","title":"商务部:决定将美国因美纳公司列入不可靠实体清单","url":"https://stock-news.laohu8.com/highlight/detail?id=1179393516","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179393516?lang=zh_cn&edition=full","pubTime":"2025-03-04 13:32","pubTimestamp":1741066369,"startTime":"0","endTime":"0","summary":"3月4日,商务部公告,为维护国家主权、安全和发展利益,根据《中华人民共和国对外贸易法》《中华人民共和国国家安全法》《中华人民共和国反外国制裁法》等有关法律,依据《不可靠实体清单规定》有关规定,不可靠实体清单工作机制决定于2025年2月4日将美国因美纳公司(Illumina, Inc.)列入不可靠实体清单。现决定对该企业采取以下处理措施:禁止其向中国出口基因测序仪。本公告未尽事宜,按《不可靠实体清单规定》执行。本公告自公布之日起实施。受此消息影响,Illumina美股夜盘短线下挫,现跌超2%。","market":"us","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"商务部:决定将美国因美纳公司列入不可靠实体清单","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN"],"gpt_icon":0},{"id":"1121211945","title":"异动解读 | Illumina盘中大跌5.42%,业绩持续下滑或为主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1121211945","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121211945?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:50","pubTimestamp":1740685842,"startTime":"0","endTime":"0","summary":"Illumina昨日在盘中遭遇大跌,股价下跌5.42%,引发了市场的广泛关注。根据Illumina最近公布的财报数据,公司营收为43.72亿美元,同比下滑约10%;净利润则为-12.23亿美元,较上年同期的正数扭亏为负。公司毛利润为28.62亿美元,较去年同期小幅下降。业绩持续下滑的背景下,Illumina股价面临着较大的压力。投资者对公司能否重新恢复盈利能力和增长动能存在疑虑,这可能是导致Illumina股价下跌的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Illumina盘中大跌5.42%,业绩持续下滑或为主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ILMN"],"gpt_icon":0},{"id":"2514334801","title":"因美纳盘中异动 下午盘股价大跌5.06%报89.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514334801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514334801?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:36","pubTimestamp":1740685003,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时36分,因美纳股票出现异动,股价大幅下跌5.06%。截至发稿,该股报89.29美元/股,成交量109.293万股,换手率0.69%,振幅4.58%。因美纳股票所在的生命科学行业中,整体跌幅为2.04%。因美纳公司简介:因美纳为生命科学和临床实验室应用提供分析遗传物质的工具和服务。因美纳的高通量技术使人类和其他大型生物的全基因组测序成为可能。因美纳还销售微阵列,可实现低成本、集中的基因筛查,主要用于消费者和农业应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228033643a256be56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4548","BK4588","BK4585","ILMN","BK4534","BK4121"],"gpt_icon":0},{"id":"2512483654","title":"因美纳跌1.08% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2512483654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512483654?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:49","pubTimestamp":1739976554,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时49分,因美纳股票出现波动,股价急速下挫1.08%。截至发稿,该股报100.00美元/股,成交量24.9823万股,换手率0.16%,振幅1.86%。因美纳股票所在的生命科学行业中,整体涨幅为0.18%。因美纳公司简介:因美纳为生命科学和临床实验室应用提供分析遗传物质的工具和服务。因美纳的高通量技术使人类和其他大型生物的全基因组测序成为可能。因美纳还销售微阵列,可实现低成本、集中的基因筛查,主要用于消费者和农业应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224914a24bfdc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4535","BK4588","ILMN","BK4585","BK4121","BK4534"],"gpt_icon":0},{"id":"2511999856","title":"Illumina Full Year 2024 Earnings: EPS Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2511999856","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511999856?lang=zh_cn&edition=full","pubTime":"2025-02-14 20:17","pubTimestamp":1739535449,"startTime":"0","endTime":"0","summary":"Illumina ( NASDAQ:ILMN ) Full Year 2024 Results Key Financial Results Revenue: US$4.37b (down 2.9% from FY 2023). Net...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":null,"property":["earning"],"language":"en","translate_title":"Illumina 2024年全年收益:每股收益未达预期","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ilmn/illumina/news/illumina-full-year-2024-earnings-eps-misses-expectations","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ILMN"],"gpt_icon":1},{"id":"2511684888","title":"华大系如何接住Illumina的泼天富贵?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511684888","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511684888?lang=zh_cn&edition=full","pubTime":"2025-02-14 09:43","pubTimestamp":1739497414,"startTime":"0","endTime":"0","summary":"Illumina公司2024财年的总收入为43.3亿美元,同比下降2%;然而,毛利润和净利润较2023年皆翻了数倍。2024年2月26日,Illumina宣布郑磊女士将担任Illumina全球高级副总裁兼大中华区总经理,并成为全球执行管理团队的一员。在此之前,Illumina大中华区总经理这一职务已空缺近半年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214110339a2454d81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","ILMN","BK4121","BK4535","BK4588","BK4585","BK4548"],"gpt_icon":0},{"id":"2510730823","title":"因美纳跌0.94% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2510730823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510730823?lang=zh_cn&edition=full","pubTime":"2025-02-12 22:31","pubTimestamp":1739370682,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日22时31分,因美纳股票出现波动,股价大幅下挫0.94%。截至发稿,该股报99.73美元/股,成交量6.3235万股,换手率0.04%,振幅0.38%。因美纳股票所在的生命科学行业中,整体跌幅为0.69%。因美纳的高通量技术使人类和其他大型生物的全基因组测序成为可能。因美纳还销售微阵列,可实现低成本、集中的基因筛查,主要用于消费者和农业应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212223123abcc5d0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4121","BK4535","BK4588","BK4534","ILMN","BK4548"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.illumina.com","stockEarnings":[{"period":"1week","weight":-0.1044},{"period":"1month","weight":-0.1166},{"period":"3month","weight":-0.4134},{"period":"6month","weight":-0.4251},{"period":"1year","weight":-0.4094},{"period":"ytd","weight":-0.4134}],"compareEarnings":[{"period":"1week","weight":-0.0252},{"period":"1month","weight":-0.0559},{"period":"3month","weight":-0.0428},{"period":"6month","weight":-0.0121},{"period":"1year","weight":0.0743},{"period":"ytd","weight":-0.0428}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Illumina, Inc.是一家生命科学用具以及用于分析基因变异和基因功能的整合系统的一流开发商、制造商和销售商。公司于1998年4月在加利福尼亚州组成,2000年7月在特拉华州完成重组。公司利用专利技术提供一系列的基因分析方案以及为高度相联的市场提供产品和服务,包括基因序列、基因类型、基因表达和分子诊断市场。该公司的客户包括领先的基因组研究中心、学术机构、政府管辖的实验室、临床研究组织以及制药公司、生物科技公司、农产品基因组鉴定研发公司和客户基因组鉴定公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.68,"avgChangeRate":0.091842},{"month":2,"riseRate":0.36,"avgChangeRate":-0.043951},{"month":3,"riseRate":0.56,"avgChangeRate":0.002218},{"month":4,"riseRate":0.6,"avgChangeRate":0.017503},{"month":5,"riseRate":0.541667,"avgChangeRate":0.038008},{"month":6,"riseRate":0.708333,"avgChangeRate":0.032137},{"month":7,"riseRate":0.708333,"avgChangeRate":0.019105},{"month":8,"riseRate":0.44,"avgChangeRate":-0.004142},{"month":9,"riseRate":0.48,"avgChangeRate":0.000211},{"month":10,"riseRate":0.56,"avgChangeRate":0.018615},{"month":11,"riseRate":0.56,"avgChangeRate":0.009053},{"month":12,"riseRate":0.64,"avgChangeRate":0.030354}],"exchange":"NASDAQ","name":"Illumina","nameEN":"Illumina"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Illumina(ILMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Illumina(ILMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Illumina,ILMN,Illumina股票,Illumina股票老虎,Illumina股票老虎国际,Illumina行情,Illumina股票行情,Illumina股价,Illumina股市,Illumina股票价格,Illumina股票交易,Illumina股票购买,Illumina股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Illumina(ILMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Illumina(ILMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}